Upgrade to SI Premium - Free Trial

Truist Securities Downgrades Amgen (AMGN) to Hold

October 14, 2024 6:05 AM
Truist Securities analyst Robyn Karnauskas downgraded Amgen (NASDAQ: AMGN) from Buy to Hold with a price target of $333.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades Hot Comments Hot Downgrades

Next Articles